The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the MHRA.

Marco Rubio has authorised an “Emergency Humanitarian Waiver” that ensures continued access to HIV treatment funded by the US.

The World Health Organization has responded to the US government’s freezing of HIV funding as part of a broader pause in foreign aid.

Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in women’s health.

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

According to new findings by the HBA and FemTechnology, there are significant systemic challenges and unmet needs in women’s healthcare

Takeda is serving as the Industry Lead in the newly launched INTERCEPT project – a multinational collaboration to identify predictive biomarkers for Crohn’s Disease.

The Healthcare Businesswomen’s Association (HBA) has announced its 2025 winners as Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US.